Pharmafile Logo
Pharmafocus logo
Advanced Search

RecipharmCobra Biologics

Showing 1 posts of 1 posts found.

Oxford BioMedica buys decommissioned facility

February 1, 2011
Manufacturing and Production Oxford BioMedica, RecipharmCobra Biologics, manufacturing

Gene therapy specialist Oxford BioMedica has said it plans to acquire a £1.9 million ($3.1m) manufacturing facility from contract manufacturer …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026